Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004153 (
atherosclerosis
)
77,401
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Childhood obesity coincides with increased numbers of circulating classical CD14
++
CD16
-
and intermediate CD14
++
CD16
+
monocytes. Monocytes are key players in the development and exacerbation of
atherosclerosis
, which prompts the question as to whether the monocytosis in childhood obesity contributes to atherogenesis over the years. Here, we dissected the monocyte gene expression profile in childhood obesity using an Illumina microarray platform on sorted monocytes of 35 obese children and 16 lean controls. Obese children displayed a distinctive monocyte gene expression profile compared to lean controls. Upon validation with quantitative PCR, we studied the association of the top 5 differentially regulated monocyte genes in childhood obesity with obesity and complexity of coronary
atherosclerosis
(SYNTAX score) in a cohort of 351 adults at risk for ischemic cardiovascular disease. The downregulation of monocyte IMPDH2 and
TMEM134
in childhood obesity was also observed in obese adults. Moreover, downregulation of monocyte
TMEM134
was associated with a higher SYNTAX
atherosclerosis
score in adults. In conclusion, childhood obesity entails monocyte gene expression alterations associated with obesity and enhanced complexity of coronary
atherosclerosis
in adults.
...
PMID:Monocyte gene expression in childhood obesity is associated with obesity and complexity of atherosclerosis in adults. 2920 85